Related Experiment Video
Updated: May 28, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Recent consensus statements in pediatric endocrinology: a selective review
Michelle Klein1, Anpalakan Sathasivam, Yeray Novoa
1Division of Pediatric Endocrinology and Diabetes, Mount Sinai Hospital, One Gustave Levly Place, Box 1616, New York, NY 10029, USA. michelle.klein@mssm.edu
Pediatric Clinics of North America
|October 11, 2011
Summary
This article synthesizes key recommendations from recent pediatric endocrine consensus statements. It provides essential clinical management guidance based on current evidence for healthcare professionals.
Area of Science:
- Endocrinology
- Pediatrics
- Clinical Practice Guidelines
Background:
- Clinical guidelines and consensus statements are crucial for organizing medical knowledge and guiding patient care.
- Numerous consensus statements are published annually, particularly in pediatric endocrinology.
- Evidence-based recommendations are fundamental for effective clinical management.
Purpose of the Study:
- To summarize the essential points from the latest consensus statements in pediatric endocrinology.
- To present updated clinical management guidelines developed by leading endocrine societies.
- To provide accessible information for healthcare professionals managing pediatric endocrine conditions.
Main Methods:
- Review and synthesis of recently published consensus statements.
- Jointly developed statements from the Lawson Wilkins Society for Pediatric Endocrinology and the European Society for Pediatric Endocrinology were prioritized.
- Paraphrasing of original statements while maintaining their intent and language.
Main Results:
- Consensus statements consolidate current knowledge for practical application.
- These statements offer evidence-based recommendations for pediatric endocrine disorders.
- The article highlights key takeaways from multiple collaborative endocrine society guidelines.
Conclusions:
- Summarized consensus statements facilitate the adoption of best practices in pediatric endocrinology.
- Adherence to these guidelines ensures standardized and effective patient care.
- This review serves as a valuable resource for clinicians seeking updated management strategies.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:21Smooth Endoplasmic Reticulum
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...